This will be a multi-center post-marketing pediatric registry study evaluating the efficacy and safety of teduglutide. This is an observational longitudinal registry of pediatric SBS patients who are using FDA approved teduglutide as per standard of care.
Pediatric specific post-marketing registry to evaluate the long-term safety and efficacy of teduglutide.